Rapid Micro Biosystems (NASDAQ:RPID) CEO Robert Jr. Spignesi Sells 12,840 Shares

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Robert Jr. Spignesi sold 12,840 shares of Rapid Micro Biosystems stock in a transaction dated Monday, February 9th. The shares were sold at an average price of $3.78, for a total transaction of $48,535.20. Following the completion of the sale, the chief executive officer owned 962,097 shares in the company, valued at approximately $3,636,726.66. This trade represents a 1.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Rapid Micro Biosystems Stock Up 8.8%

RPID opened at $4.08 on Wednesday. Rapid Micro Biosystems, Inc. has a twelve month low of $1.86 and a twelve month high of $4.94. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42. The company has a 50-day moving average price of $3.66 and a 200 day moving average price of $3.39. The company has a market cap of $180.83 million, a PE ratio of -4.04 and a beta of 1.38.

Institutional Trading of Rapid Micro Biosystems

Several large investors have recently added to or reduced their stakes in RPID. Goldman Sachs Group Inc. purchased a new position in shares of Rapid Micro Biosystems during the 4th quarter worth $160,000. Geode Capital Management LLC raised its stake in Rapid Micro Biosystems by 6.3% during the fourth quarter. Geode Capital Management LLC now owns 217,568 shares of the company’s stock worth $631,000 after purchasing an additional 12,881 shares during the period. Nano Cap New Millennium Growth Fund L P purchased a new position in Rapid Micro Biosystems during the fourth quarter worth about $72,000. Hudson Bay Capital Management LP acquired a new position in Rapid Micro Biosystems in the 3rd quarter valued at about $38,000. Finally, Susquehanna International Group LLP grew its stake in shares of Rapid Micro Biosystems by 12.6% in the 3rd quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock valued at $195,000 after buying an additional 6,528 shares during the period. 52.60% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Wall Street Zen lowered Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a research note on Saturday, January 17th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Rapid Micro Biosystems currently has an average rating of “Hold” and a consensus price target of $8.00.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.